Mitigating Risks Critical To Ending Polio Globally

PLOS Medicine: Sailing in Uncharted Waters: Carefully Navigating the Polio Endgame
Elizabeth Miller, consultant epidemiologist in the Immunisation, Hepatitis and Blood Safety Department at Public Health England, and T. Jacob John, consultant pediatrician at the Child Health Foundation, discuss the risks and benefits of the use of oral poliovirus vaccines (OPV) and inactivated polio vaccine (IPV). They conclude, “Until all risks of OPV cessation are understood and mitigated, continued IPV coverage will be necessary” (10/4).